XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total
Balance (in shares) at Dec. 31, 2022 73,104,692        
Balance at the beginning of the period at Dec. 31, 2022 $ 72 $ 2,305,020 $ 4,796 $ (2,656,974) $ (347,086)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 806,407        
Exercise of options $ 1 23,770     23,771
Restricted stock vesting and issuance (in shares) 773,157        
Restricted stock vesting and issuance, net $ 1       1
Issuance of common stock in connection with an employee stock purchase plan (in shares) 117,304        
Issuance of common stock in connection with an employee stock purchase plan   3,805     3,805
Issuance of common stock in connection with a milestone payable (in shares) 657,462        
Issuance of common stock in connection with a milestone payable $ 1 29,569     29,570
Share-based compensation expense   85,128     85,128
Net Income (Loss)       (470,812) (470,812)
Comprehensive income (loss)     4,813   4,813
Balance (in shares) at Sep. 30, 2023 75,459,022        
Balance at the end of the period at Sep. 30, 2023 $ 75 2,447,292 9,609 (3,127,786) (670,810)
Balance (in shares) at Jun. 30, 2023 75,318,233        
Balance at the beginning of the period at Jun. 30, 2023 $ 75 2,416,904 (1,431) (2,994,816) (579,268)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 113,795        
Exercise of options   3,446     3,446
Restricted stock vesting and issuance (in shares) 26,994        
Share-based compensation expense   26,942     26,942
Net Income (Loss)       (132,970) (132,970)
Comprehensive income (loss)     11,040   11,040
Balance (in shares) at Sep. 30, 2023 75,459,022        
Balance at the end of the period at Sep. 30, 2023 $ 75 2,447,292 9,609 (3,127,786) (670,810)
Balance (in shares) at Dec. 31, 2023 75,708,889        
Balance at the beginning of the period at Dec. 31, 2023 $ 75 2,466,233 (1,285) (3,283,578) (818,555)
Increase (Decrease) in Stockholders' Equity          
Retired shares (in shares) (20)        
Exercise of options (in shares) 200,927        
Exercise of options   5,320     5,320
Restricted stock vesting and issuance (in shares) 935,183        
Restricted stock vesting and issuance, net $ 1       1
Issuance of common stock in connection with an employee stock purchase plan (in shares) 107,145        
Issuance of common stock in connection with an employee stock purchase plan   1,973     1,973
Share-based compensation expense   57,376     57,376
Net Income (Loss)       (297,409) (297,409)
Comprehensive income (loss)     (3,058)   (3,058)
Balance (in shares) at Sep. 30, 2024 76,952,124        
Balance at the end of the period at Sep. 30, 2024 $ 76 2,530,902 (4,343) (3,580,987) (1,054,352)
Balance (in shares) at Jun. 30, 2024 76,900,123        
Balance at the beginning of the period at Jun. 30, 2024 $ 76 2,510,574 (16,498) (3,474,333) (980,181)
Increase (Decrease) in Stockholders' Equity          
Retired shares (in shares) (20)        
Exercise of options (in shares) 19,483        
Exercise of options   573     573
Restricted stock vesting and issuance (in shares) 32,538        
Share-based compensation expense   19,755     19,755
Net Income (Loss)       (106,654) (106,654)
Comprehensive income (loss)     12,155   12,155
Balance (in shares) at Sep. 30, 2024 76,952,124        
Balance at the end of the period at Sep. 30, 2024 $ 76 $ 2,530,902 $ (4,343) $ (3,580,987) $ (1,054,352)